Navigate Global Drug Pricing with Confidence
From International Reference Pricing to US MFN policy, pharmaceutical pricing has never been more complex. At Symaptics, we built SyMAP—the AI-powered toolkit that cuts through the noise, delivering transparent models, explainable insights, and strategic clarity across your entire portfolio.
The SyMAP Platform
SyMAP is built to grow with your needs. Our modular platform includes IRP simulation, comprehensive MFN analysis across US government payer programs, and integrated global pricing strategy tools. Explore the capabilities below.
SyMAP IRP — International Reference Pricing with AI
Our flagship tool, SyMAP IRP, is a specialized AI-powered platform for International Reference Pricing simulation and analysis. Built specifically for pharmaceutical pricing and market access teams, SyMAP IRP combines rigorous IRP modelling with explainable AI to deliver transparent, actionable insights.
SyMAP MFN — Most Favored Nation Drug Pricing Toolkit
SyMAP MFN is our comprehensive toolkit for modelling Most Favored Nation (MFN) drug pricing across US government payer programs. As MFN policies reshape pharmaceutical pricing through international reference benchmarks, SyMAP MFN brings together the tools you need to analyse, simulate, and strategically respond to these evolving requirements—including the CMS GENEROUS Model for Medicaid, the proposed GUARD Model for Medicare Part B, and the GLOBE Model for Medicare Part D.
SyMAP Global Pricing — End-to-End Pricing Strategy
SyMAP Global Pricing integrates domestic and international pricing analysis into a unified strategic framework. In today’s interconnected regulatory landscape, decisions made in one market have direct consequences in others—a discounted launch in a single country can cascade through IRP networks and reappear in U.S. benchmarks. Our platform enables true end-to-end pricing analysis, connecting U.S. channel exposure, ex-US list and net prices, IRP pathways, and MFN benchmarks.
Expert Analysis
MFN Policy Insights
The MFN Hub is your go-to resource for understanding Most Favored Nation drug pricing policy. Explore deep-dive analysis, strategic implications, and implementation details from the Symaptics team—covering GENEROUS, GLOBE, GUARD, and the evolving global pricing landscape.
MFN and the Shift of Risk for Ex-US Markets
Although MFN policies are designed for the US, they shift pricing and policy risk onto ex-US health systems. How ex-US payers adapt will shape future access and investment.
Redefining Ex-US Success in an MFN World
MFN pricing policies are transforming international pharmaceutical strategy. Companies must now balance local opportunities against global pricing risks, making launch timing and market selection critical.
The End of Two Silos
Why pharmaceutical pricing is now a single global challenge. MFN creates unprecedented integration between U.S. and ex-US pricing strategies.
GLOBE & GUARD: MFN Comes to Medicare
Comprehensive analysis of the two Medicare MFN models—19-country reference baskets, benchmark methodologies, and key implementation differences.
The Fine Print: Hidden Details in GLOBE & GUARD
Three overlooked provisions that could reshape your MFN strategy—PPP adjustments, benchmark lock-in, and Method II pricing dynamics.
GENEROUS: Medicaid’s MFN Test
What CMS’s voluntary Medicaid model means for manufacturers—8-country basket, GNUP calculations, and supplemental rebate obligations.
Custom AI Solutions
Looking for something beyond the platform? We build bespoke AI tools for pharmaceutical pricing and market access—whether that’s custom Excel add-ins, strategic assessments, or team training programmes.
Intelligent AI Toolkits
→
Advanced Data Solutions
→
AI Training Programs
→
Who We Are
Chris McDonald PhD
Founder
Chris brings over a decade of experience in pharmaceutical pricing and market access, with a strong background in both the pharmaceutical industry and consulting. Over the past five years, he has built extensive expertise developing IRP simulation models—work that now forms the foundation of SyMAP IRP—and is actively applying this experience to the rapidly evolving MFN sector.
Specializing in intelligent AI toolkits for pharmaceutical pricing and advanced data solutions for strategic market access insight, Chris develops bespoke AI-driven solutions that address complex challenges and deliver real value. With a commitment to purposeful AI integration, these tools are tailored to meet the unique needs of the pharmaceutical industry.
Client Feedback
A fantastic AI-powered tool, tailored to our specific needs as a market access consultancy. Chris was very professional and easy to work with, developing the tool on a tight timeline and with outputs that we were really happy with. Would recommend in a heartbeat.
The bespoke services provided by Symaptics significantly improved our market access efforts.
Get in Touch
Ready to transform your pharmaceutical pricing and market access strategy? Let’s discuss how SyMAP can help your team.